"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This trial is a 12-week, randomized, double-blind, placebo controlled, multicenter,
4-treatment parallel group study of the safety and efficacy of JZP-110 in the treatment of
excessive sleepiness in adult subjects with narcolepsy.